The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

nDreams secures multi-million dollar contract

16 Aug 2018 07:00

RNS Number : 9905X
Mercia Technologies PLC
16 August 2018
 

 

RNS

16 August 2018

 

Mercia Technologies PLC

("Mercia", the "Company" or the "Group") 

 

nDreams secures multi-million dollar contract with high profile global technology firm

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, is pleased to announce that nDreams Limited ("nDreams") has won a multi-million dollar contract with one of the world's foremost virtual reality ("VR") technology companies.

 

This new contract for nDreams, a leading European developer and publisher focused on VR gaming and experiences content, represents the company's most significant contract win to date.

 

Mercia, which holds a 45.6% direct equity stake in nDreams, initially financed nDreams' pivot from developing content for PlayStation Home Virtual Worlds to successfully becoming a specialist in virtual reality content provision. Following early support from Mercia's managed funds, Mercia made its first direct investment into nDreams in December 2014. Since then nDreams has been working with the leading global names in the VR industry including Sony PlayStation, Oculus, HTC, Google and Microsoft.

 

Dr Mark Payton, Chief Executive Officer of Mercia Technologies PLC, said: "This contract is not only highly significant for nDreams, as it reinforces the substantial potential value of this exciting VR business, but it is also a reflection of the wider inherent value held in the Mercia direct investment portfolio.

 

Today's announcement, which follows the recent Oxford Genetics announcement, is the second multi-million pound contract which Mercia's two largest direct investments by value have recently secured and taken together, demonstrate the tangible commercial progress which the portfolio is making. We expect to announce further positive news from our direct investment portfolio in due course."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

 

Martin Glanfield, Chief Financial Officer

 

www.merciatech.co.uk

 

 

 

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys (NOMAD and Joint Broker)

 

 

 

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (Joint Broker)

 

 

 

Buchanan

+44 (0)20 7466 5000

Bobby Morse, Chris Lane, Stephanie Watson

 

www.buchanan.uk.com

 

 

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third-party funds (now with circa £400million under management following recent mandate wins) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £63million directly across its portfolio of 'Emerging Stars'.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTEQLBFVVFXBBB
Date   Source Headline
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares
15th Feb 20249:31 amRNSTransaction in Own Shares
9th Feb 20249:46 amRNSTransaction in Own Shares
8th Feb 20249:41 amRNSTransaction in Own Shares
7th Feb 20249:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.